LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Aeglea BioTherapeutics…

Aeglea BioTherapeutics Tech Stack

Aeglea BioTherapeutics uses 8 technology products and services including Cloudflare, MySQL, Google Font API, and more. Explore Aeglea BioTherapeutics's tech stack below.

  • Cloudflare
    Content Management System
  • MySQL
    Database
  • Google Font API
    Font Scripts
  • Font Awesome
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • HTTP/3
    Miscellaneous
  • PHP
    Programming Languages

Media & News

Aeglea BioTherapeutics's Email Address Formats

Aeglea BioTherapeutics uses at least 2 format(s):
Aeglea BioTherapeutics Email FormatsExamplePercentage
FLast@aegleabio.comJDoe@aegleabio.com
78%
First.Last@aegleabio.comJohn.Doe@aegleabio.com
21%
FirstLast@aegleabio.comJohnDoe@aegleabio.com
1%
FLast@aeglea.comJDoe@aeglea.com
100%

Frequently Asked Questions

Where is Aeglea BioTherapeutics's headquarters located?

Minus sign iconPlus sign iconAeglea BioTherapeutics's main headquarters is located at 805 Las Cimas Pkwy Suite 100 Austin, Texas 78746 US. The company has employees across 2 continents, including North AmericaEurope.

What is Aeglea BioTherapeutics's phone number?

Minus sign iconPlus sign icon You can contact Aeglea BioTherapeutics's main corporate office by phone at +1-512-942-2935. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Aeglea BioTherapeutics's stock symbol?

Minus sign iconPlus sign iconAeglea BioTherapeutics is a publicly traded company; the company's stock symbol is SYRE.

What is Aeglea BioTherapeutics's official website and social media links?

Minus sign iconPlus sign iconAeglea BioTherapeutics's official website is aeglea.com and has social profiles on LinkedIn.

How much revenue does Aeglea BioTherapeutics generate?

Minus sign iconPlus sign icon As of August 2024, Aeglea BioTherapeutics's annual revenue reached $15M.

What is Aeglea BioTherapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconAeglea BioTherapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Aeglea BioTherapeutics have currently?

Minus sign iconPlus sign iconAs of August 2024, Aeglea BioTherapeutics has approximately 51 employees across 2 continents, including North AmericaEurope. Key team members include Chief Legal Officer And Corporate Secretary: H. A. K.Chief Development Officer: E. B.Chief Operating Officer: C. T.. Explore Aeglea BioTherapeutics's employee directory with LeadIQ.

What industry does Aeglea BioTherapeutics belong to?

Minus sign iconPlus sign iconAeglea BioTherapeutics operates in the Biotechnology Research industry.

What technology does Aeglea BioTherapeutics use?

Minus sign iconPlus sign iconAeglea BioTherapeutics's tech stack includes CloudflareMySQLGoogle Font APIFont AwesomejQuery MigrateMicrosoftHTTP/3PHP.

What is Aeglea BioTherapeutics's email format?

Minus sign iconPlus sign iconAeglea BioTherapeutics's email format typically follows the pattern of . Find more Aeglea BioTherapeutics email formats with LeadIQ.

How much funding has Aeglea BioTherapeutics raised to date?

Minus sign iconPlus sign icon As of August 2024, Aeglea BioTherapeutics has raised $210M in funding. The last funding round occurred on Jun 22, 2023 for $210M.

When was Aeglea BioTherapeutics founded?

Minus sign iconPlus sign iconAeglea BioTherapeutics was founded in 2013.
Aeglea BioTherapeutics

Aeglea BioTherapeutics

Biotechnology ResearchTexas, United States51-200 Employees

With its acquisition of Spyre Therapeutics, Aeglea is shifting its disease focus to inflammatory bowel disease (IBD). Spyre combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for IBD.

For more information, please visit http://aeglea.com.

Section iconCompany Overview

Headquarters
805 Las Cimas Pkwy Suite 100 Austin, Texas 78746 US
Phone number
+1-512-942-2935
Website
aeglea.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SYRE
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $210M

    Aeglea BioTherapeutics has raised a total of $210M of funding over 3 rounds. Their latest funding round was raised on Jun 22, 2023 in the amount of $210M.

  • $10M$50M

    Aeglea BioTherapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $210M

    Aeglea BioTherapeutics has raised a total of $210M of funding over 3 rounds. Their latest funding round was raised on Jun 22, 2023 in the amount of $210M.

  • $10M$50M

    Aeglea BioTherapeutics's revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.